NCT00343551 Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. Status COMPLETED Phase PHASE3
NCT00343499 The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) Status TERMINATED Phase PHASE4
NCT00343226 An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. Status COMPLETED Phase PHASE4
NCT00342940 Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older Status WITHDRAWN Phase PHASE2
NCT00340834 Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase Status COMPLETED Phase PHASE3
NCT00338936 Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study) Status COMPLETED Phase PHASE3
NCT00338247 EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer Status APPROVED_FOR_MARKETING Phase N/A
NCT00333567 Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery Status COMPLETED Phase PHASE4
NCT00333489 Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension Status COMPLETED Phase PHASE4
NCT00333138 Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00333047 Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy Status COMPLETED Phase PHASE2/PHASE3
NCT00332709 Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer Status COMPLETED Phase PHASE3
NCT00331864 SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Status COMPLETED Phase PHASE3
NCT00329966 Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older Status COMPLETED Phase PHASE2
NCT00329927 Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects Status COMPLETED Phase PHASE2
NCT00329381 Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy Status COMPLETED Phase PHASE4
NCT00327587 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension Status COMPLETED Phase PHASE3
NCT00327145 A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy Status COMPLETED Phase PHASE3